Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy
- 1 April 1999
- journal article
- case report
- Published by Elsevier in The American Journal of Cardiology
- Vol. 83 (7) , 1146
- https://doi.org/10.1016/s0002-9149(99)00034-x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Preclinical and clinical pharmacology of cerivastatinThe American Journal of Cardiology, 1998
- Rhabdomyolysis After Taking Atorvastatin With GemfibrozilThe American Journal of Cardiology, 1998
- Long-Term Efficacy and Safety of Fenofibrate and a Statin in the Treatment of Combined HyperlipidemiaThe American Journal of Cardiology, 1998
- Safety and Efficacy of Long-Term Statin-Fibrate Combinations in Patients With Refractory Familial Combined HyperlipidemiaThe American Journal of Cardiology, 1997
- Rhabdomyolysis associated with simvastatin-gemfibrozil therapy.Southern Medical Journal, 1997
- Pravastatin‐induced rhabdomyolysis in a patient with mixed connective tissue diseaseArthritis & Rheumatism, 1996
- Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safetyEuropean Heart Journal, 1995
- Dual bezafibrate-simvastatin therapy for combined hyperlipidaemiaJournal of Clinical Pharmacy & Therapeutics, 1994
- Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemiaThe American Journal of Medicine, 1993
- Gemfibrozil-lovastatin therapy for primary hyperlipoproteinemiasThe American Journal of Cardiology, 1992